Allied Market Research

2024

Latam Radiopharmaceuticals Market

LATAM Radiopharmaceuticals Market Size, Share, Competitive Landscape and Trend Analysis Report by Type and by Application : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Diagnostics and Biotech

  • Jun 2024

  • Pages: NA

  • Tables: NA

  • Charts: NA

Select an option
Online Only (10% Off) $3,075 $2,768
Data Pack/Excel (10% Off) $2,850 $2,565
Single User License (10% Off) $4,245 $3,821
Five User License (10% Off) $5,055 $4,550
Enterprise User License (10% Off) $6,270 $5,643
Library Membership (15% Off) $1,175 $999
Enquiry Now
Author's: | Roshan Deshmukh
Publish Date:
Enquire Before Buying Customization Request Speak with Analyst

Get Sample to Email

  LATAM Radiopharmaceuticals Market Report Highlights

Aspects Details
icon_5
By Type
  • CONTRAST REAGENTS
  • NUCLEAR REAGENTS
icon_6
By Application
  • DIAGNOSTICS
  • DRUG DISCOVERY & DEVELOPMENT
  • R&D
icon_7
By Region
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
icon_8
Key Market Players

NURIX Pharmaceuticals, Biocad, AUSPEC Pharmaceuticals, Jubilant Life Sciences Ltd., Amersham Health, McKesson Corporation, Mallinckrodt plc, Arc Evolution Corp., Triad Isotopes, Almac Group

Loading Table Of Content...

LATAM Radiopharmaceuticals Market

Global Opportunity Analysis and Industry Forecast, 2023-2032

help@alliedmarketresearch.com